Search clinical trials for: 68Ga-BBN-IRDye800CW

Total 1717 results

University Health Network, Toronto

Completed

68Ga-DOTATATE PET for Management of Neuroendocrine Tumors

Neuroendocrine Tumors

Canada
Mayo Clinic

Active, not recruiting

Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia

Osteomalacia

United States
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.

Primary Myelofibrosis

China
Philogen S.p.A.

Recruiting

A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors (FAPrimo)

Breast Cancer | Colorectal Cancer | Pancreas Adenocarcinoma | Oesophageal Cancer

Italy
Affiliated Hospital of Jiangnan University

Recruiting

Tracer Targeting FAP PET Imaging in Patients

Cancer

China
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Dotatate to Locate Coronary Plaques at High-risk of Myocardial Infarction (DOLPHIN)

Atheroscleroses, Coronary

Netherlands
Ruijin Hospital

Completed

Cardiac Fibroblast Activation Detected by 68Ga-FAPI PET/MR

Myocardial Remodeling After AMI

China
Peking University Cancer Hospital & Institute

Completed

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

Solid Tumor

China
Wuhan Union Hospital, China

Recruiting

Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma

Malignant Neoplasm of Liver

China
University of Cambridge
Sanofi

Recruiting

Molecular Imaging in Fabry Disease of the Heart

Fabry Disease, Cardiac Variant

United Kingdom
Ruijin Hospital

Recruiting

Fibroblast Activating Protein Inhibitor PET Imaging in Lupus Nephritis

Lupus Nephritis

China
The First Affiliated Hospital of Xiamen University

Recruiting

A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer

Ovarian Cancer

China
British Columbia Cancer Agency

Recruiting

177Lu-HTK03170 in mCRPC With PSMA Positive Disease

Prostate Cancer Metastatic | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate Cancer

Canada
Xijing Hospital

Not yet recruiting

Clinical Study of 68Ga Labeled HER2 Affibody Analogues

HER2-positive Breast Cancer and Gastric Cancer
First Affiliated Hospital of Fujian Medical University

Recruiting

68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases

Positron-Emission Tomography

China
Peking University Cancer Hospital & Institute

Recruiting

PD-L1 Targeting Molecular Imaging of Solid Tumors

Gastrointestinal Tumors

China
Jewish General Hospital

Completed

SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors

Neuroendocrine Tumors

Canada
Rigshospitalet, Denmark

Completed

Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer

Head and Neck Cancer

Denmark
Assistance Publique Hopitaux De Marseille

Completed

[68 Ga]-DOTANOC PET/CT in GEP-NETs (GEP-NOC)

Gastroenteropancreatic Neuroendocrine Tumors

France
German Cancer Research Center
University Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-Nürnberg

Completed

Ga-68-PSMA-11 in High-risk Prostate Cancer

Prostate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode Metastasis

Austria, Germany
Clarity Pharmaceuticals Ltd

Recruiting

64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) (COMBAT)

Prostatic Neoplasms | Castration-Resistant

United States
Huashan Hospital

Recruiting

A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer

Prostate Specific Membrane Antigen Positive Metastatic Prostate Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Peking University; Peking University Cancer Hospital & Institute

Recruiting

68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer

Malignant Tumor | Positron Emission Tomography | Fibroblast Activation Protein Inhibitor

China
Huashan Hospital

Recruiting

Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer

HER2-positive Breast Cancer

China
UMC Utrecht

Recruiting

Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer (SENGA)

Endometrial Cancer

Netherlands
Peking Union Medical College Hospital

Active, not recruiting

Characterizing Breast Cancer With 68Ga-FAPI PET/CT (PFB-01)

Breast Cancer

China
Cytosite Biopharma Inc.
University of Alabama at Birmingham

Completed

Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers.

Healthy Volunteers

United States
Radboud University Medical Center

Terminated

Visualizing Beta Cells After Islet Transplantation (GLP1-transpl)

Type 1 Diabetes Mellitus

Netherlands, Sweden
Clarity Pharmaceuticals Ltd

Active, not recruiting

64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE) (SABRE)

Biochemical Recurrence of Malignant Neoplasm of Prostate

United States
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer

Pancreatic Cancer

China
Turku University Hospital
University of Lausanne Hospitals; Leiden University Medical Center

Recruiting

68Ga-NODAGA-RGD PET in Patients With an Occluded Coronary Artery (RGDHeart)

Coronary Artery Disease

Finland, Netherlands, Switzerland
Rigshospitalet, Denmark

Recruiting

uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung

Non-small Cell Lung Cancer | Malignant Pleural Mesothelioma | Large Cell Neuroendocrine Carcinoma of the Lung

Denmark
Rigshospitalet, Denmark

Unknown

uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness

Prostate Cancer

Denmark
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Terminated

68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Italy
Building Block Nutritionals, LLC
Paidion Research, Inc.

Completed

Phase II Growth and Safety Study of an Infant Formula for Healthy Term Infants

Infant Development

United States
Zhongnan Hospital

Recruiting

The Function of PET Molecular Imaging Targeting Fibroblast Activation Protein in the Hepatobiliary Malignancies

Hepatobiliary Diseases

China
Peter MacCallum Cancer Centre, Australia

Recruiting

Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions (SPECIFIC)

Invasive Fungal Infections

Australia
Lale Kostakoglu

Terminated

68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)

Neuroendocrine Tumors | Carcinoid Tumors

United States
Zhongnan Hospital

Recruiting

68Ga-FAPI PET/CT in Malignant Tumors

Malignant Neoplasm | PET/CT | Fibroblast Activation Protein Inhibitor

China
Huashan Hospital

Recruiting

[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer

Non-small Cell Lung Cancer

China
Peking Union Medical College Hospital

Recruiting

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Neuroendocrine Tumor | Neuroblastoma | Pheochromocytoma | Paraganglioma

China
Peking University Cancer Hospital & Institute
Peking University Health Science Center

Recruiting

68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy

Cancer

China
Wuhan Union Hospital, China

Active, not recruiting

Visualized Monitoring of Fibrosis Formation in Heart Failure With 68GA-FAPI PET

Heart Failure | Positron Emission Tomography

China
First Affiliated Hospital of Fujian Medical University

Unknown

68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer

Metastasis | Tumor | Positron-Emission Tomography

China
University of Michigan

Completed

Phase 1A Study of the Safety of KSP/QRH Dimer

Healthy Adults

United States
Huashan Hospital

Recruiting

Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors

Neoplasms | Positron-Emission Tomography

China
Huashan Hospital

Recruiting

A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
SmartNuclide Biopharma

Recruiting

Phase I Clinical Trial of 68Ga-NOTA-SNA002

Solid Tumor | Positron-Emission Tomography(PET)

China
Alberta Health services

Recruiting

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

Neuroendocrine Tumors (NET)

Canada
The First Affiliated Hospital of Xiamen University

Recruiting

PET Imaging of LAG-3 Expression

Tumor, Solid

China

Search clinical trials for: 68Ga-BBN-IRDye800CW

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations